CME Group Sets New Financial Records in Q1 2026: Key Insights for Investors

April 22, 2026 – Chicago: CME Group Inc. (NASDAQ: CME), the world’s leading derivatives marketplace, has reported a highly robust set of financial results for the first quarter of 2026. The company delivered several record-breaking numbers, underscoring strong operational performance and significant momentum across its global platforms.

Key Highlights from Q1 2026 Results

• Record Revenue and Profitability: Revenue surged to an all-time high of \$1.9 billion, a 14% increase from the previous year. Operating income also hit a record, reaching \$1.3 billion, while net income soared 20% to \$1.2 billion. Diluted earnings per share (EPS) climbed to \$3.18 (GAAP) and \$3.36 on an adjusted basis.
• Exceptional Trading Volume: Average daily volume (ADV) reached a record 36.2 million contracts, representing a 22% year-over-year increase. Notably, all six asset classes posted record volumes.
• Global Expansion: Non-U.S. ADV hit an all-time high of 11.4 million contracts (up 30% YoY), with particularly strong growth in APAC (up 33%) and EMEA (up 29%).
• Clearing and Transaction Fees: Revenue from these activities rose to a record \$1.5 billion.
• Market Data Revenue: Achieved a new high of \$224 million for the quarter.
• Capital Management: As of March 31, 2026, CME Group held \$2.6 billion in cash (including \$200 million deposited with the Fixed Income Clearing Corporation) and maintained \$3.4 billion in debt. The company returned significant capital to shareholders, paying approximately \$2.7 billion in dividends and repurchasing \$536 million in common shares in Q1.
• Operational Efficiencies: The company delivered over \$85 billion in average daily margin savings to its clients, a new record. It also announced the extension of its FICC cross-margining agreement to end-user clients, set to launch later in the month.

Comments from Management

CME Group Chairman and CEO Terry Duffy stated, “In a world in which risk has become the new normal, 2026 is off to a record-breaking start as clients around the world turn to CME Group’s trusted, regulated markets to hedge across asset classes and in all trading environments. Robust demand for our products drove Q1 average daily volume up 22% to a record 36.2 million contracts, including records in all six asset classes. This exceptional market participation translated directly into record financial performance, with revenue rising 14% and adjusted net income and diluted EPS increasing 20%. Efficiencies provided to our client base also hit a new high in Q1 with over \$85 billion in average daily margin savings.”

Duffy further emphasized the company’s commitment to innovation, stating, “Looking ahead, innovation remains central to our growth strategy. We will continue to work closely with our clients as we expand the range of products and services we provide to help them manage risk and pursue opportunities in a rapidly evolving marketplace.”

Detailed Financial Results (Q1 2026 vs. Q1 2025)

Additional Operating Statistics

• Quarterly ADV by Product (in thousands):
  • Interest Rates: 18,674
  • Equity Indexes: 8,655
  • Foreign Exchange: 1,722
  • Energy: 3,985
  • Agricultural Commodities: 2,042
  • Metals: 1,153
• Quarterly Average Rate Per Contract (RPC): \$0.652

Balance Sheet & Capital Returns

• Cash and Equivalents: \$2.4 billion (down from \$4.4 billion at December 31, 2025 due to dividend payments and share repurchases)
• Total Assets: \$202.0 billion
• Total Liabilities: \$175.4 billion
• Shareholders’ Equity: \$26.6 billion
• Dividends Paid (Q1): \$2.7 billion
• Share Repurchases (Q1): \$536 million

Key Developments and Forward-Looking Statements

• FICC Cross-Margining Expansion: CME Group is set to extend its Fixed Income Clearing Corporation (FICC) cross-margining agreement to end-user clients later this month. This development should further enhance capital efficiencies for clients and potentially attract more trading activity.
• Innovation Focus: The company continues to prioritize product and service innovation to meet client needs in fast-evolving markets, which could be a significant competitive advantage.

Risks and Considerations for Shareholders

The company cautioned that forward-looking statements are subject to a variety of risks and uncertainties, including but not limited to: increased competition; technological changes; regulatory changes; cyber and operational risks; fluctuations in trading volume and market data revenues; and macroeconomic and geopolitical developments. Shareholders should carefully review the company’s recent SEC filings for a comprehensive discussion of these risks.

Outlook

CME Group’s record-setting start to 2026 positions the company well for further growth, supported by robust demand for risk management, continued global expansion, and a strong focus on innovation and operational efficiency. The combination of high trading volumes, expanding client solutions, and ongoing capital return initiatives make this quarter’s results highly significant and potentially share price moving.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consider their own risk tolerance before making any investment decisions. Past performance is not indicative of future results. The information provided is based on public filings and statements made by CME Group as of April 22, 2026.

View CME GROUP INC. Historical chart here